Topics

Urovant Sciences Company Profile

15:14 EST 19th February 2020 | BioPortfolio

Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions. Urovant’s lead product candidate, vibegron, is an oral, once-daily, small molecule beta-3 agonist being evaluated for the treatment of OAB with symptoms of urge urinary incontinence, urgency, and urinary frequency. Urovant has licensed global rights, excluding Japan and certain Asian territories, for the development and commercialization of vibegron. Urovant’s second product candidate, hMaxi-K, is a novel gene therapy being developed for patients with OAB who have failed oral pharmacological therapy. Urovant intends to develop treatments for additional urologic diseases. For more information, please visit www.urovant.com. www.urovant.com.


News Articles [577 Associated News Articles listed on BioPortfolio]

Urovant ramps up spending on Codexis ingredient ahead of commercial production

Urovant Sciencesâ preparations to file for US approval of vibegron add to Codexisâ sales in the second quarter.

Urovant Sciences to Present at the 38th Annual J.P. Morgan Healthcare Conference

Urovant Sciences (Nasdaq: UROV) announced today that Chief Executive Officer Keith Katkin will give a presentation at 4:30 p.m. Pacific / 7:30 p.m. Eastern on Wednesday, January 15, 2020, at the 38th...

Urovant seeks FDA approval for overactive bladder drug

A New Drug Application was submitted by Urovant Sciences to seek the FDA's approval for its beta-3 adrenergic agonist vibegro -More- 

Urovant Sciences to Report 2019 Third Fiscal Quarter Financial Results

Urovant Sciences (Nasdaq: UROV) announced today that it will report 2019 third fiscal quarter financial results after the close of U.S. financial markets on Thursday, February 13, 2020. Management ...

Urovant Sciences to Report 2019 First Fiscal Quarter Financial Results

Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced it will report 2019...

Urovant Sciences to Report 2019 Second Fiscal Quarter Financial Results

Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced it will report 2019...

Urovant secures $200mm loan from Sumitomo Dainippon

To support the concurrent signing of a definitive agreement with Sumitomo Dainippon Pharma Co. Ltd. (SDP) to create a strategic alliance (for which the partners signed an MOU last month), Roivant Scie...

Urovant Sciences licenses OAB gene therapy

Drugs and Medications [45 Associated Drugs and Medications listed on BioPortfolio]

Mondoxyne [oculus innovative sciences]

Mondoxyne NL 50mg

Mondoxyne nl 100mg [oculus innovative sciences]

Monodoxyne NL 100mg

Deltasone [oculus innovative sciences]

Deltasone 20mg prednisone tablets

Complera access [gilead sciences, inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir dis...

Emtriva [gilead sciences, inc.]

These highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule, for oral use EMTRIVA (e...

PubMed Articles [575 Associated PubMed Articles listed on BioPortfolio]

Therapeutic Applications of Ethanol: A Review.

To review knowledge on therapeutic uses of ethanol and the latter's effectiveness and safety profiles in a range of indications.

Making Sense of the Senses in Aging Research.

Testing the Geroscience Hypothesis: Early Days.

Multitarget Therapy: An Effective and Safe Therapeutic Regimen for Lupus Nephritis.

We evaluated the effectiveness and safety of various multitarget therapies for inducing remission in lupus nephritis patients.

Leveraging the Power of Networks to Support Healthy Aging.

Clinical Trials [270 Associated Clinical Trials listed on BioPortfolio]

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

Dietary Pattern and Metabolic Health Study

This is a single-blind, randomized trial. Based on inclusion and exclusion criteria, 450 eligible volunteers, who were 25-60 years old, with overweight/obese and prediabetes are assigned t...

Companies [1141 Associated Companies listed on BioPortfolio]

Urovant Sciences

Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions. Urovant’s lead product ...

Urovant Sciences Ltd.

Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions. Urovant’s lead product ...

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Origin Sciences Limited

Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...

T.A. Sciences

T.A. Sciences www.TASciences.com is the first company in the world to offer its clients the ability to fight aging through the emerging science of telomere biology. T.A. Sciences was founded by Noel T...

More Information about "Urovant Sciences" on BioPortfolio

We have published hundreds of Urovant Sciences news stories on BioPortfolio along with dozens of Urovant Sciences Clinical Trials and PubMed Articles about Urovant Sciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Urovant Sciences Companies in our database. You can also find out about relevant Urovant Sciences Drugs and Medications on this site too.

Quick Search

Relevant Topic

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...


Corporate Database Quicklinks



Searches Linking to this Company Record